<DOC>
	<DOCNO>NCT02310295</DOCNO>
	<brief_summary>Purpose : To compare effect macular photocoagulation without intravitreal bevacizumab ( IVB ) triamcinolone ( IVTA ) treatment diabetic macular edema ( DME ) . Casuistic Methods : 58 eye 44 patient diffuse DME randomize receive either IVB + focal/grid laser ( IVB-Laser , n=19 ) , IVTA + focal/grid laser ( IVTA-Laser , n=16 ) focal/grid laser alone ( Laser , n=23 ) . Ophthalmic evaluation , include best-corrected visual acuity ( BCVA ) , intraocular pressure ( IOP ) central macular thickness ( CMT ) perform baseline monthly 12 month .</brief_summary>
	<brief_title>Prospective , Randomized Clinical Trial Comparing Macular Photocoagulation With Without Intravitreal Bevacizumab Triamcinolone Treatment Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1. clinically significant diabetic macular edema ( DME ) diffuse leakage involve center fovea , DME great 275 micron OCT examination 2 . BCVA 0.3 LogMAR ( logarithm small angle visual resolution ) ( 20/40 ) 1.6 LogMAR ( 20/800 ) 3. sign inform Consent . 1 . HbA1c level great 10 % 2. thromboembolic event history ( include myocardial infarction stroke ) 3. vitreomacular traction OCT 4. coagulation disorder 5. macular ischemia fluorescein angiography examination 6. proliferative diabetic retinopathy require treatment 7. eye surgery 8. history ocular hypertension glaucoma 9. ocular pathology opinion investigator , could macular edema change visual acuity study period ( example , retinal vascular occlusion , uveitis inflammatory eye disease , neovascular glaucoma ) 10. systemic corticosteroid therapy 11. condition could affect documentation 12. previous treatment diabetic macular edema .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Diabetic retinopathy</keyword>
	<keyword>Macular edema</keyword>
	<keyword>Anti-VEGF</keyword>
	<keyword>Triamcinolone</keyword>
</DOC>